MingMed Biotech
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $110M
Investors
- 11
About MingMed Biotech
Established in 2019 and based in Guangzhou, China, MingMed Biotech is a medical company that focuses on the research and development of pharmaceutical products. The development team includes 5 national distinguished experts. The company engaged in pharmaceutical research and development based on First-in-class. The company's product lines include ophthalmic drugs, small molecule immune drugs, medical beauty drugs, pet drugs and cell therapy.
Who invested in MingMed Biotech
11 investors across 2 rounds
See all investors in MingMed Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MingMed Biotech
Who invested in MingMed Biotech?
MingMed Biotech has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MingMed Biotech raised?
MingMed Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MingMed Biotech last raise money?
MingMed Biotech's most recent round on record is a Series A, in Sep 2021.
What does MingMed Biotech do?
Established in 2019 and based in Guangzhou, China, MingMed Biotech is a medical company that focuses on the research and development of pharmaceutical products.
Where is MingMed Biotech headquartered?
MingMed Biotech is headquartered in Guangzhou, China.
Which VCs invest in companies like MingMed Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MingMed Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MingMed Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.